FSSAI Restricts Ashwagandha Use to Roots and Extracts Only

The Food Safety and Standards Authority of India (FSSAI) recently updated the Ashwagandha regulatory guidelines for food products. This new advisory clarifies which parts of the Withania somnifera plant are safe for human consumption in supplements and nutraceuticals. Specifically, the regulator now permits only the roots and their extracts in health supplements. This decision aims to standardize safety across the growing nutraceutical market in India.

Safety Concerns and Ashwagandha Regulatory Guidelines

As per the 2016 Regulations, Schedule IV identifies specific plant parts allowed in food products. Currently, FSSAI allows only Ashwagandha roots due to their well-documented safety profile. However, many manufacturers previously utilized leaves in their formulations. Notably, studies suggest that leaves contain high levels of reactive withanolides like Withaferin-A. This compound may pose safety risks, including potential liver toxicity and gastrointestinal distress. Consequently, the Ministry of Ayush and FSSAI now prohibit leaf extracts in any form to protect public health.

Compliance and Enforcement for Food Business Operators

Food Business Operators (FBOs) must ensure strict adherence to these provisions immediately. Any deviation from these standards will lead to penalties under the Food Safety and Standards Act, 2006. Furthermore, authorities have requested state-level commissioners to maintain strict vigilance. Therefore, licensing officers will monitor product labels to ensure transparency regarding the plant parts used. Additionally, manufacturers must reformulate any products currently containing prohibited leaf material. This alignment between regulators ensures a safer environment for traditional medicine and wellness products.

Frequently Asked Questions

Q1: Which specific parts of the Ashwagandha plant does FSSAI permit in food?

Under the current regulations, FSSAI only permits the use of Ashwagandha roots and their extracts in food products.

Q2: Why did FSSAI ban the use of Ashwagandha leaves?

Authorities banned the leaves because they contain high levels of specific compounds like Withaferin-A, which might cause liver toxicity or neurotoxic effects.

Q3: Does this regulation apply to Ayurvedic drugs as well?

Yes, the Ministry of Ayush has issued similar directives to drug manufacturers to use only roots and avoid leaves in their products.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. FSSAI issues advisory on Ashwagandha use in food products; permits only rootsand extract - ETHealthworld


2. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016.


3. Ministry of Ayush Advisory on the usage of Withania somnifera (Ashwagandha) leaves.